Borel, F., Cardozo, B., Cox, A., Li, W., Hoffman, A., ElMallah, M., & Mueller, C. (2016). 167. Genome Editing to Generate the First Mouse Model of Alpha-One Antitrypsin Deficiency, the Leading Cause of Genetic COPD. In Molecular Therapy (Vol. 24, pp. S65–S65). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)32976-8

Borel, Florie, Brynn Cardozo, Andrew Cox, Weiying Li, Andrew Hoffman, Mai ElMallah, and Christian Mueller. “167. Genome Editing to Generate the First Mouse Model of Alpha-One Antitrypsin Deficiency, the Leading Cause of Genetic COPD.” In Molecular Therapy, 24:S65–S65. Elsevier BV, 2016. https://doi.org/10.1016/s1525-0016(16)32976-8.

Borel F, Cardozo B, Cox A, Li W, Hoffman A, ElMallah M, et al. 167. Genome Editing to Generate the First Mouse Model of Alpha-One Antitrypsin Deficiency, the Leading Cause of Genetic COPD. In: Molecular Therapy. Elsevier BV; 2016. p. S65–S65.

Borel, Florie, et al. “167. Genome Editing to Generate the First Mouse Model of Alpha-One Antitrypsin Deficiency, the Leading Cause of Genetic COPD.” Molecular Therapy, vol. 24, Elsevier BV, 2016, pp. S65–S65. Crossref, doi:10.1016/s1525-0016(16)32976-8.

Borel F, Cardozo B, Cox A, Li W, Hoffman A, ElMallah M, Mueller C. 167. Genome Editing to Generate the First Mouse Model of Alpha-One Antitrypsin Deficiency, the Leading Cause of Genetic COPD. Molecular Therapy. Elsevier BV; 2016. p. S65–S65.